How much is ALX Oncology worth in 2026?

ALX Oncology has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has ALX Oncology raised?

ALX Oncology has raised N/A in total funding across 1 funding rounds.

ALX Oncology

Drug Discovery

ALX Oncology valuation and funding history | Last updated: January 30, 2026 | 1 funding rounds

Current Valuation

N/A

As of January 30, 2026

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$150.0M

Last Funding

Jan 2026

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 30, 2026	PIPE	$150.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

ALX Oncology is currently valued at N/A as of January 30, 2026.

Track ALX Oncology Valuation Updates

Get notified when ALX Oncology raises new funding or valuation changes

Explore More Data

Detailed analysis for ALX Oncology

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock ALX Oncology's valuation history, funding rounds, and growth metrics.

No credit card required

What is ALX Oncology Worth in 2026?

ALX Oncology is a leading private company in the Drug Discovery sector. Track ALX Oncology's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How ALX Oncology Valuation is Determined

Private company valuations like ALX Oncology's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.